Physician profile
Michael R Nelson
NPI 1871514323
$7,162.32
in general payments reported to CMS, 2019-2025
10 companies · $14.37 in 2025
The $14.37 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $31.39 · 2021: $13.10 · 2022: $6,848 · 2023: $22.84 · 2024: $97.03 · 2025: $14.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,791.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.98 | 2019-2020 | |
| Minerva Surgical, INC | $53.14 | 2020-2025 | |
| C. R. Bard, INC. & Subsidiaries | $47.50 | 2022-2024 | Bd Onclarity |
| Abbvie INC. | $41.99 | 2024 | |
| Boston Scientific Corporation | $22.84 | 2023 | Solyx Sis System |
| Exeltis, USA INC. | $18.97 | 2024 | Slynd |
| Axonics, INC. | $18.48 | 2024 | Bulkamid |
| Merck Sharp & Dohme LLC | $16.26 | 2019 | |
| Olympus America INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.